Ethanolamine-O-sulfate[1]
|
| Names
|
Preferred IUPAC name
2-Aminoethyl hydrogen sulfate
|
| Other names
Aminoethyl sulfate; 2-Aminoethyl hydrogen sulphate; Sulfuric acid mono 2-aminoethyl ester; WAS-34
|
| Identifiers
|
CAS Number
|
- 926-39-6
Y
|
3D model (JSmol)
|
|
| Abbreviations
|
EOS
|
| ChemSpider
|
- 63409
Y
|
| EC Number
|
|
|
|
|
| UNII
|
- 9C8F910HLK
Y
|
InChI
InChI=1S/C2H7NO4S/c3-1-2-7-8(4,5)6/h1-3H2,(H,4,5,6) NKey: WSYUEVRAMDSJKL-UHFFFAOYSA-N N
|
|
|
| Properties
|
Chemical formula
|
C2H7NO4S
|
| Molar mass
|
141.14 g·mol−1
|
| Melting point
|
277 °C (531 °F; 550 K) (decomposes)
|
| Hazards
|
| GHS pictograms
|
|
| GHS Signal word
|
Warning
|
GHS hazard statements
|
H302, H315, H319, H335
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
N verify (what is Y N ?)
|
| Infobox references
|
|
|
|
Tracking categories (test):
Ethanolamine-O-sulfate (EOS) is an ester of sulfuric acid and ethanolamine. EOS is a GABA transaminase inhibitor which prevents the metabolism of GABA.[2] It is used as a biochemical tool in studies involving GABA.
EOS is also a diuretic[3] and an anticonvulsant.[4]
References
- ↑ 2-Aminoethyl hydrogen sulfate at Sigma-Aldrich
- ↑ "Ethanolamine-O-sulfate enhances gamma-aminobutyric acid secretion into hypophysial portal blood and lowers serum prolactin concentrations". Neuroendocrinology 37 (5): 397–9. 1983. doi:10.1159/000123580. PMID 6646351.
- ↑ German Patent DE2345291: Diuretic aminoalkyl sulfates; Somani, Pitambar; Martin, Donald Lyons (1974)
- ↑ Anlezark, Gill; Horton, Roger W.; Meldrum, Brian S.; Sawaya, M. Christina B. (1976). "Anticonvulsant action of ethanolamine-O-sulfate and di-n-propylacetate and the metabolism of γ-aminobutyric acid (GABA) in mice with audiogenic seizures". Biochemical Pharmacology 25 (4): 413–417. doi:10.1016/0006-2952(76)90343-9. PMID 779794.
Anticonvulsants (N03) |
|---|
| GABAergics | | GABAAR PAMs |
- Barbiturates: Barbexaclone
- Metharbital
- Methylphenobarbital
- Pentobarbital
- Phenobarbital#
- Primidone; Carbamates: Felbamate; Benzodiazepines: Clobazam
- Clonazepam
- Clorazepate
- Diazepam#
- Lorazepam#
- Midazolam
- Nimetazepam
- Nitrazepam
- Temazepam; Others: Bromide (potassium bromide, sodium bromide)
- Imepitoin
- Paraldehyde
- Stiripentol
|
|---|
| GABA-T inhibitors |
- Fatty acids (and related): Valproate
- Valpromide
- Valproate pivoxil
- Vigabatrin
|
|---|
| Others |
- GABAR agonists: Progabide; GAT-1 inhibitors: Tiagabine
|
|---|
|
|---|
Channel modulators | | Sodium blockers |
- Hydantoins: Ethotoin
- Fosphenytoin
- Mephenytoin
- Phenytoin#; Ureides: Acetylpheneturide
- Chlorphenacemide
- Phenacemide‡
- Pheneturide; Fatty acids: Valproate
- Valpromide
- Valproate pivoxil; Carboxamides: Carbamazepine#
- Eslicarbazepine acetate
- Oxcarbazepine; Others: Lacosamide
- Lamotrigine#
- Rufinamide
- Topiramate
- Zonisamide
|
|---|
| Calcium blockers |
- Oxazolidinediones: Ethadione
- Paramethadione
- Trimethadione; Succinimides: Ethosuximide#
- Mesuximide
- Phensuximide; Gabapentinoids: Gabapentin
- Pregabalin; Others: Imepitoin
- Lamotrigine#
- Topiramate
- Zonisamide
|
|---|
| Potassium openers | |
|---|
|
|---|
| Others | | CA inhibitors |
- Sulfonamides: Acetazolamide
- Ethoxzolamide
- Sultiame
- Topiramate
- Zonisamide
|
|---|
| Others |
- Albutoin
- Beclamide
- Brivaracetam
- Cannabidiol
- Etiracetam
- Levetiracetam
- Perampanel
|
|---|
|
|---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
 | Original source: https://en.wikipedia.org/wiki/Ethanolamine-O-sulfate. Read more |